BURZYKOWSKI, Tomasz

Email Alert RSS Feed

Profile

Full Name
BURZYKOWSKI, Tomasz
Email
tomasz.burzykowski@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Internal UHasselt:  BUYSE, Marc

Results 61-80 of 85 (Search time: 0.019 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
612005A meta-analytic validation framework for continuous outcomesMOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, TomaszBook SectionB2
622005A quantitative study of tumor response and progression-free survival as surrogate endpoints for overall survival in first-line treatment of metastatic breast cancerBURZYKOWSKI, Tomasz; Piccart, MJ; Sledge, G; Carmichael, J; Luck, HJ; Mackey, John R.; Nabholtz, JM; Paridaens, R; Biganzoli, L; Jassem, J; Blohmer, JU; Bontenbal, M; Bonneterre, J; Chan, S; Atalay, G.; Therasse, P; BUYSE, MarcJournal ContributionM
632005Effects of taxanes alone or in combination with anthracyclines on tumor response, progression-free survival and overall survival in first-line chemotherapy of patients with metastatic breast cancer: an analysis of 4,256 patients randomized in 12 trialsPiccart, MJ; BURZYKOWSKI, Tomasz; Sledge, G; Luck, HJ; Mackey, John R.; Nabholtz, JM; Paridaens, R; Biganzoli, L; Jassem, J; Blohmer, JU; Bontenbal, M; Bonneterre, J; Chan, S; Atalay, G.; Carmichael, J; BUYSE, Marc; Therasse, PJournal ContributionM
642005Progression-free survival (PFS) as a surrogate for overall survival (OS) in patients with advanced colorectal cancer: An analysis of 3159 patients randomized in 11 trials.BUYSE, Marc; BURZYKOWSKI, Tomasz; Carroll, K; Michiels, Stefan; Pignon, JP; Piedbois, PJournal ContributionM
652004Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpointsALONSO ABAD, Ariel; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena; SHKEDY, Ziv; TIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; BUYSE, MarcJournal ContributionA1
662004A perspective on surrogate endpoints in controlled clinical trialsMOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; BUYSE, MarcJournal ContributionA1
672004Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trialsSakamoto, J.; Ohashi, Y.; Hamada, C.; BUYSE, Marc; BURZYKOWSKI, Tomasz; Piedbois, P.Journal ContributionA1
682004The validation of surrogate endpoints by using data from randomized clinical trials: a case-study in advanced colorectal cancerBURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, MarcJournal ContributionA1
692003Validation of biomarkers as surrogates for clinical endpointsBUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, Luc; RENARD, Didier; BURZYKOWSKI, Tomasz; GEYS, Helena; MOLENBERGHS, GeertBook SectionB3
702003Simplified hierarchical linear models for the evaluation of surrogate endpointsTIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; MOLENBERGHS, Geert; RENARD, Didier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Parmar, Mahesh; Stijnen, Theo; Wolfinger, RussJournal ContributionA1
712003Using the 'expected' survival to explain differences between the results of randomized trials: a case in advanced ovarian cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Parmar, Mahesh; Torri, Valter; Omura, George; Colombo, Nicoletta; Williams, Chris; Conte, Pierfranco; Vermorken, JanJournal ContributionA1
722003Validation of a longitudinally measured surrogate for a time-to-event endpointRENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, LucJournal ContributionA1
732002Statistical challenges in the evaluation of surrogate endpoints in randomized trialsMOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, Tomasz; ALONSO ABAD, ArielJournal ContributionA1
742002Challenges in the methodology for the validation of surrogate endpoints in randomized trialsMOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, TomaszProceedings PaperC2
752002Validation of surrogate endpoints in multiple randomized clinical trials with discrete outcomesRENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
762001Methodology for the validation of surrogate endpoints in multiple randomized experimentsMOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, MarcProceedings PaperC2
772001Methodology of the validation of surrogate endpoints in multiple randomized experimentsMOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, MarcProceedings PaperC2
782001Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpointsBURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, DidierJournal ContributionA1
792001Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancerBUYSE, Marc; Thirion, Pierre; Carlson, Robert; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Piedbois, PascalJournal ContributionA1
802000Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpointsBURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, DidierProceedings PaperC1
show all